(Q40160323)

English

Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort

scientific article published on 26 December 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

0 references

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

1

object named as

Adeera Levin

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Claudio Rigatto

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Brendan Barrett

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

François Madore

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Norman Muirhead

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Daniel Holmes

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Catherine M Clase

7

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Mila Tang

8

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ognjenka Djurdjev

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

CanPREDDICT Investigators

10

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

language of work or name

0 references

publication date

26 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1037-1047

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Prevalence of chronic kidney disease in population-based studies: systematic review

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Prevalence of chronic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Prevalence and risk factors associated with chronic kidney disease in adults over 40 years: a population study from Central China

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Prevalence of chronic kidney disease in China: a cross-sectional survey

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Effect of chronic kidney disease and comorbid conditions on health care costs: A 10-year observational study in a general population

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

A predictive model for progression of chronic kidney disease to kidney failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Diagnostic accuracy of cystatin C-based eGFR equations at different GFR levels in children.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Update on fibroblast growth factor 23 in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Biomarkers in chronic kidney disease: a review

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Assessing the performance of prediction models: a framework for traditional and novel measures

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Estimation of time-dependent area under the ROC curve for long-term risk prediction

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Development and validation of a general population renal risk score

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

A multi-marker approach to predict incident CKD and microalbuminuria

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Risk prediction models for patients with chronic kidney disease: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Discussions of the kidney disease trajectory by elderly patients and nephrologists: a qualitative study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Age and association of kidney measures with mortality and end-stage renal disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

FGF23 as a novel therapeutic target

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Effect of RAS inhibition on TGF-β, renal function and structure in experimentally induced diabetic hypertensive nephropathy rats

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

The German Chronic Kidney Disease (GCKD) study: design and methods.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT479

21 January 2018

Identifiers

10.1093/NDT/GFT479

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40160323&oldid=1887763571"